New study: which first treatment works best for severe aplastic anemia?

This study compares two first-line treatments for severe aplastic anemia, a condition where the bone marrow stops making enough blood cells. One treatment is a stem cell transplant from a half-matched donor, and the other is drug therapy that suppresses the immune system. The study will follow 116 people aged 14 to 70 to see which approach leads to better survival and recovery, while also tracking side effects like infections and graft-versus-host disease.